These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25231174)

  • 1. Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.
    Young D; Fong DM; Lawlor PA; Wu A; Mouravlev A; McRae M; Glass M; Dragunow M; During MJ
    Gene Ther; 2014 Dec; 21(12):1029-40. PubMed ID: 25231174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glutamine synthetase and glutamate dehydrogenase in the latent phase and chronic phase in the kainate model of temporal lobe epilepsy.
    Hammer J; Alvestad S; Osen KK; Skare Ø; Sonnewald U; Ottersen OP
    Glia; 2008 Jun; 56(8):856-68. PubMed ID: 18381650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation.
    Fedele DE; Gouder N; Güttinger M; Gabernet L; Scheurer L; Rülicke T; Crestani F; Boison D
    Brain; 2005 Oct; 128(Pt 10):2383-95. PubMed ID: 15930047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy.
    van der Hel WS; Notenboom RG; Bos IW; van Rijen PC; van Veelen CW; de Graan PN
    Neurology; 2005 Jan; 64(2):326-33. PubMed ID: 15668432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy.
    Eid T; Thomas MJ; Spencer DD; Rundén-Pran E; Lai JC; Malthankar GV; Kim JH; Danbolt NC; Ottersen OP; de Lanerolle NC
    Lancet; 2004 Jan; 363(9402):28-37. PubMed ID: 14723991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.
    Theofilas P; Brar S; Stewart KA; Shen HY; Sandau US; Poulsen D; Boison D
    Epilepsia; 2011 Mar; 52(3):589-601. PubMed ID: 21275977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia.
    Weller ML; Stone IM; Goss A; Rau T; Rova C; Poulsen DJ
    Neuroscience; 2008 Sep; 155(4):1204-11. PubMed ID: 18620031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploinsufficiency of glutamine synthetase increases susceptibility to experimental febrile seizures.
    van Gassen KL; van der Hel WS; Hakvoort TB; Lamers WH; de Graan PN
    Genes Brain Behav; 2009 Apr; 8(3):290-5. PubMed ID: 19170755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.
    Aronica E; Zurolo E; Iyer A; de Groot M; Anink J; Carbonell C; van Vliet EA; Baayen JC; Boison D; Gorter JA
    Epilepsia; 2011 Sep; 52(9):1645-55. PubMed ID: 21635241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity.
    Simantov R; Crispino M; Hoe W; Broutman G; Tocco G; Rothstein JD; Baudry M
    Brain Res Mol Brain Res; 1999 Feb; 65(1):112-23. PubMed ID: 10036313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
    Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
    Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
    Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
    Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-UCA1 inhibits the astrocyte activation in the temporal lobe epilepsy via regulating the JAK/STAT signaling pathway.
    Wang H; Yao G; Li L; Ma Z; Chen J; Chen W
    J Cell Biochem; 2020 Oct; 121(10):4261-4270. PubMed ID: 31909503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine kinase gene modified mesenchymal stem cell transplantation retards seizure severity and associated cognitive impairment in a temporal lobe epilepsy rat model.
    Zhou Q; Zhang N; Wang M; Zhao Q; Zhu S; Kang H
    Epilepsy Res; 2024 Feb; 200():107303. PubMed ID: 38306957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy.
    Bouilleret V; Ridoux V; Depaulis A; Marescaux C; Nehlig A; Le Gal La Salle G
    Neuroscience; 1999 Mar; 89(3):717-29. PubMed ID: 10199607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrogliosis is a possible player in preventing delayed neuronal death.
    Jeong HK; Ji KM; Min KJ; Choi I; Choi DJ; Jou I; Joe EH
    Mol Cells; 2014 Apr; 37(4):345-55. PubMed ID: 24802057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC1A2 mediates refractory temporal lobe epilepsy with an initial precipitating injury by targeting the glutamatergic synapse pathway.
    Zhang Y; Dong H; Duan L; Yuan G; Liang W; Li Q; Zhang X; Pan Y
    IUBMB Life; 2019 Feb; 71(2):213-222. PubMed ID: 30360015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
    Hubbard JA; Szu JI; Yonan JM; Binder DK
    Exp Neurol; 2016 Sep; 283(Pt A):85-96. PubMed ID: 27155358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted overexpression of glutamate transporter-1 reduces seizures and attenuates pathological changes in a mouse model of epilepsy.
    Peterson AR; Garcia TA; Cullion K; Tiwari-Woodruff SK; Pedapati EV; Binder DK
    Neurobiol Dis; 2021 Sep; 157():105443. PubMed ID: 34246771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats.
    van der Hel WS; Hessel EV; Bos IW; Mulder SD; Verlinde SA; van Eijsden P; de Graan PN
    Eur J Neurosci; 2014 Dec; 40(12):3711-9. PubMed ID: 25350774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.